Orbimed Advisors LLC Compass Therapeutics, Inc. Transaction History
Orbimed Advisors LLC
- $3.21 Billion
- Q1 2025
A detailed history of Orbimed Advisors LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 22,362,850 shares of CMPX stock, worth $68.7 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
22,362,850
Previous 22,362,850
-0.0%
Holding current value
$68.7 Million
Previous $32.4 Million
31.03%
% of portfolio
1.32%
Previous 0.88%
Shares
3 transactions
Others Institutions Holding CMPX
# of Institutions
121Shares Held
101MCall Options Held
2.52MPut Options Held
3.1M-
Tang Capital Management LLC San Diego, CA11.1MShares$33.9 Million1.36% of portfolio
-
Blackstone Inc New York, NY10MShares$30.8 Million0.09% of portfolio
-
Bio Impact Capital LLC Cambridge, MA8.44MShares$25.9 Million2.97% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$20.3 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.96MShares$15.2 Million0.56% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $311M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...